| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -62,162 | -44,324 |
| Stock-based compensation expense | 11,553 | 6,473 |
| Depreciation and amortization | 3,460 | 2,449 |
| Non-cash lease expense | 1,173 | 772 |
| Non-cash interest expense | 2,045 | 1,335 |
| Amortization of premium on investments, net | 1,717 | 1,028 |
| Change in provision for inventories | -203 | -160 |
| Change in provision for credit losses | 650 | 1,622 |
| Loss on disposal of property and equipment | -5 | -2 |
| Loss on extinguishment of term loan | -7,685 | -7,685 |
| Accounts receivable | -2,007 | 893 |
| Inventories | -10,301 | -7,297 |
| Prepaid expenses and other assets | -360 | -468 |
| Accounts payable | -2,164 | -2,502 |
| Accrued compensation and related benefits | -5,966 | -7,032 |
| Accrued expenses and other current liabilities | -1,216 | 610 |
| Accrued warranty liability | -575 | -698 |
| Deferred revenue | 1,979 | 999 |
| Operating lease liabilities | -1,326 | -866 |
| Accrued interest | -2,695 | -2,695 |
| Net cash used in operating activities | -36,806 | -30,486 |
| Purchases of property and equipment | 575 | 415 |
| Purchases of investment securities | 193,748 | 153,653 |
| Sales and maturities of investment securities | 88,049 | 44,827 |
| Net cash used in investing activities | -106,274 | -109,241 |
| Proceeds from stock option exercises and espp purchases | 639 | 408 |
| Proceeds from issuance of term loans, net of issuance costs | 98,270 | 98,270 |
| Repayment of term loan and extinguishment costs | 204,954 | 204,954 |
| Proceeds from issuance of series a convertible preferred stock, net of issuance costs | 161,548 | 161,548 |
| Net cash provided by financing activities | 55,503 | 55,272 |
| Net decrease in cash, cash equivalents and restricted cash | -87,577 | -84,455 |
| Cash and cash equivalents at beginning of period | 127,343 | - |
| Cash and cash equivalents at end of period | 39,766 | - |
Outset Medical, Inc. (OM)
Outset Medical, Inc. (OM)